Fifth Annual Young Researchers Roundtable Breakfast Brings Voice to Metastatic Breast Cancer
Susan G. Komen® NCTC Hosts Young Researchers Roundtable Breakfast Bringing Voice to those Living with Metastatic Breast Cancer
October 13 is recognized each year as Metastatic Breast Cancer Day
RALEIGH, NC – Susan G. Komen® North Carolina Triangle to the Coast will host its fifth annual Young Researchers Roundtable Breakfast: Hearing the Metastatic Voice, bringing attention and urgency to metastatic breast cancer (MBC) treatment, support, and needed research.
Metastatic breast cancer (MBC), also called stage IV or advanced breast cancer, is breast cancer that has spread beyond the breast to other organs in the body (most often the bones, lungs, liver or brain.) MBC is not a type of breast cancer, but rather the most advanced stage of all types of breast cancer. It causes the majority of the 40,000 expected breast cancer deaths each year in the U.S. Both women and men can be diagnosed with MBC. In the U.S., it’s estimated at least 154,000 people are currently living with MBC.
“Finding the cures to breast cancer must include open dialogue between researchers, medical professionals, survivors and individuals living with metastatic breast cancer,” said Pam Kohl, executive director at Komen North Carolina Triangle to Coast. “With Komen’s Bold Goal to reduce the current number of breast cancer deaths by 50% in the U.S. by 2026, we depend on the hard work and dedication of our Komen scholars and researchers to help us reach that goal.”
With the support of presenting sponsor, Pfizer Oncology, the program will consist of panelist presentations by individuals vested in MBC research and treatment including Dr. Carey K. Anders, associate professor of Medicine at the University of North Carolina School of Medicine and co-leader of the UNC Lineberger Comprehensive Cancer Center Breast Program; Dr. Sarah Sammons, medical oncologist at Duke University Medical Center/ Duke Cancer Institute specializing in the care of patients with breast cancer; and Rhonda Howell, patient advocate who is living with metastatic breast cancer at age 36 and Board of Directors member at METAvivor Research and Support.
The roundtable event is unique opportunity connecting early-career breast cancer researchers with established local Komen Scholars, physicians, scientists, individuals living with MBC, breast cancer survivors, and co-survivors in a meaningful way. The breakfast will be held on Monday, October 15, 2018, from 9:00 a.m. to 12:00 p.m., at The Carolina In at 211 Pittsboro Street in Chapel Hill, N.C.
In addition to the panel program, young researchers will provide brief overviews of their breast cancer research projects. Following the researcher overviews, there will be table discussions about breast cancer research and treatment and its impact on patient care with a focus on the care of those living with MBC.
The breakfast is the first event in Komen NCTC’s Finding Solutions Research Series highlighting the important work taking place in laboratories locally and nationally toward finding the cures to breast cancer. Comprised of three events, Komen’s series brings together a passionate audience of researchers, advocates, and those impacted by breast cancer.
About Susan G. Komen® North Carolina Triangle to the Coast
Susan G. Komen is the world’s largest breast cancer organization, funding more breast cancer research than any other nonprofit while providing real-time help to those facing the disease. Komen has set a Bold Goal to reduce the current number of breast cancer deaths by 50 percent in the U.S. by 2026. Komen was founded in 1982 by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life. Komen North Carolina Triangle to the Coast (NCTC) is working to better the lives of those facing breast cancer in the local community. Through events like the Komen Triangle Race for the Cure® and Komen Wilmington Race for the Cure®, Komen NCTC has invested over $13 million in community breast health programs in its 29-county service area and has helped contribute to the more than $988 million invested globally in research. For more information, call (919) 493-2873 or visit komennctc.org.
Meet the Panelists
Carey K. Anders, MD, is an Associate Professor of Medicine at the University of North Carolina (UNC) School of Medicine and an active member of the UNC Lineberger Comprehensive Cancer Center (LCCC) and co-leader of the LCCC Breast Program. As a clinician-scientist, she is Section Leader for the UNC Breast Program, Leader of the UNC breast cancer clinical trials program, and co-Director of the multi-disciplinary brain metastases clinic at UNC.
Sarah Sammons, MD, is a medical oncologist at Duke University Medical Center/ Duke Cancer Institute, specializing in the care of patients with breast cancer. Her goal is to provide the best possible care for these patients and to discover new and scientifically grounded treatments that can improve outcomes in difficult to treat and aggressive breast cancer.
Rhonda Howell is a 39 year-old native of Wake Forest, N.C. Rhonda was diagnosed with metastatic breast cancer at age 36, and has mets in her liver and bones (spine, hips, left femur, ribs). She is a patient advocate, as well as a Board of Directors member at METAvivor Research and Support. Rhonda and her husband co-hosted the first Triangle Metsquerade in April 2018, which raised net proceeds of $101,000, all of which benefited METAVIVOR to fund Stage IV metastatic breast cancer research.